title: Histiocytic sarcoma: secondary neoplasm or "transdifferentiation" in the setting of B-acute lymphoblastic leukemia.
authors.affiliation: The University of Texas MD Anderson Cancer Center.
authors.forename: Beenu
authors.initials: B
authors.lastname: Thakral
authors.affiliation: The University of Texas MD Anderson Cancer Center.
authors.forename: Joseph D
authors.identifier: 0000-0003-2621-3584
authors.initials: JD
authors.lastname: Khoury
mesh_terms: D000328:Adult; D019943:Amino Acid Substitution; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D020558:GTP Phosphohydrolases / Q000235:genetics; D054747:Histiocytic Sarcoma / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D020125:Mutation, Missense; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage; D016159:Tumor Suppressor Protein p53 / Q000235:genetics; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D008565:Membrane Proteins; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D014750:Vincristine; D011239:Prednisolone; D015122:Mercaptopurine; D020558:GTP Phosphohydrolases; C579846:NRAS protein, human; D008727:Methotrexate